Prof. Valérie VANHOORNE works in the field of Pharmaceutical Technology at the Department of Pharmaceutics, Ghent University (UGent). She started her PhD under the supervision of Prof. Jean-Paul Remon and Prof. Chris Vervaet in the Laboratory of Pharmaceutical Technology (UGent). In 2016, she obtained her PhD in Pharmaceutical Sciences studying continuous agglomeration technologies. She continued working in the lab as a postdoctoral researcher focusing on innovative manufacturing processes for oral solid dosage forms. Initially, she worked as a postdoctoral researcher in close collaboration with Janssen Pharmaceutica (Belgium) on the development of predictive empirical models for continuous direct compression and platform formulations for continuous twin-screw granulation. Later on, as a doctor-assistant, she also worked on patient-tailored dosage forms and performed a research stay at the University of Düsseldorf.
Her current research line will focus on formulation and process development of continuous manufacturing processes and on personalization of dosage forms (via 3D-printing and multi-particulate dosage forms) to meet the needs of specific patient populations.
NEWS FROM THE CLUSTER
Upcoming PSSRC Meeting
The 17th Annual PSSRC Symposium will take place in Cambridge, UK
29th August – 1st September 2023
For more information, registration & abstract submission:
The TU Graz proposes a MOOC: Technology for Continuous Production of Medicines
Feeding, blending, granulation (wet and dry), and tableting are the basic process steps for the production of a tablet. In this course, you will learn about advanced high-speed technologies that enable the production of medicines via continuous processes that are controlled in real-time.
Utrecht University, the Quodbach team is currently recruiting a PhD student for a joint project with Glatt GmbH in Germany.
There, powders will be engineered to enhance the capabilities of SLS 3D printing. The remaining 3 years of the PhD will be spend in Utrecht where the printing studies will take place. The powders will be further improved in close collaboration with scientists from Glatt.
